Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Nine Months of 2016
October 24, 2016
Share
Autobio Diagnostics Co., Ltd. announced earnings results for the first nine months of 2016. For the nine months, the company reported basic earnings per share of CNY 0.67 million, weighted average return on net assets was 28.00%.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.